Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 101020-79-5
2. Ademethionine 1,4-butanedisulfonate
3. [(3s)-3-amino-3-carboxypropyl]-[[(2s,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium;butane-1,4-disulfonate;butane-1,4-disulfonic Acid
4. S-adenosylmethione-1,4-butanedisulfonate
5. Mfcd11111819
6. Akos024259134
7. Ac-32157
8. As-13888
9. D83220
10. J-000309
11. S-adenosylmethione-1,4-butanedisulfonate Sodium Salt
12. (3s)-5-[(3-amino-3-carboxypropyl)methylsulfonio]-5-deoxy-adenosine1,4-butanedisulfonate1,4-butanedisulfonate(2:1:2)
| Molecular Weight | 1451.6 g/mol |
|---|---|
| Molecular Formula | C42H74N12O28S8 |
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 38 |
| Rotatable Bond Count | 27 |
| Exact Mass | 1450.2501191 g/mol |
| Monoisotopic Mass | 1450.2501191 g/mol |
| Topological Polar Surface Area | 749 Ų |
| Heavy Atom Count | 90 |
| Formal Charge | 0 |
| Complexity | 1040 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Ademetionine 1,4-Butanedisulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ademetionine 1,4-Butanedisulfonate, including repackagers and relabelers. The FDA regulates Ademetionine 1,4-Butanedisulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ademetionine 1,4-Butanedisulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ademetionine 1,4-Butanedisulfonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ademetionine 1,4-Butanedisulfonate supplier is an individual or a company that provides Ademetionine 1,4-Butanedisulfonate active pharmaceutical ingredient (API) or Ademetionine 1,4-Butanedisulfonate finished formulations upon request. The Ademetionine 1,4-Butanedisulfonate suppliers may include Ademetionine 1,4-Butanedisulfonate API manufacturers, exporters, distributors and traders.
click here to find a list of Ademetionine 1,4-Butanedisulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ademetionine 1,4-Butanedisulfonate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ademetionine 1,4-Butanedisulfonate active pharmaceutical ingredient (API) in detail. Different forms of Ademetionine 1,4-Butanedisulfonate DMFs exist exist since differing nations have different regulations, such as Ademetionine 1,4-Butanedisulfonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ademetionine 1,4-Butanedisulfonate DMF submitted to regulatory agencies in the US is known as a USDMF. Ademetionine 1,4-Butanedisulfonate USDMF includes data on Ademetionine 1,4-Butanedisulfonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ademetionine 1,4-Butanedisulfonate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ademetionine 1,4-Butanedisulfonate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ademetionine 1,4-Butanedisulfonate Drug Master File in Korea (Ademetionine 1,4-Butanedisulfonate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ademetionine 1,4-Butanedisulfonate. The MFDS reviews the Ademetionine 1,4-Butanedisulfonate KDMF as part of the drug registration process and uses the information provided in the Ademetionine 1,4-Butanedisulfonate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ademetionine 1,4-Butanedisulfonate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ademetionine 1,4-Butanedisulfonate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ademetionine 1,4-Butanedisulfonate suppliers with KDMF on PharmaCompass.
Ademetionine 1,4-Butanedisulfonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ademetionine 1,4-Butanedisulfonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ademetionine 1,4-Butanedisulfonate GMP manufacturer or Ademetionine 1,4-Butanedisulfonate GMP API supplier for your needs.
A Ademetionine 1,4-Butanedisulfonate CoA (Certificate of Analysis) is a formal document that attests to Ademetionine 1,4-Butanedisulfonate's compliance with Ademetionine 1,4-Butanedisulfonate specifications and serves as a tool for batch-level quality control.
Ademetionine 1,4-Butanedisulfonate CoA mostly includes findings from lab analyses of a specific batch. For each Ademetionine 1,4-Butanedisulfonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ademetionine 1,4-Butanedisulfonate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ademetionine 1,4-Butanedisulfonate EP), Ademetionine 1,4-Butanedisulfonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ademetionine 1,4-Butanedisulfonate USP).
LOOKING FOR A SUPPLIER?
